James Fry
Neurology with Special Qualifications in Child Neurology · Nashville, TNNPI 1659482305
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $50,150 of the $79,899 with a category attached, or 62.8%. Supernus Pharmaceuticals, Inc. accounts for 65.0% of it on its own, with 39 other manufacturers making up the rest. Reporting peaked in 2021 at $39,782 and has fallen 94.6% since, to $2,137 in 2025.
Across 972 payments — averaging $82.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$52K
- Ironshore Pharmaceuticals Inc.$13K
- SK Life Science, Inc.$3K
- Neurocrine Biosciences, Inc.$2K
- Neurelis, Inc.$1K
- Aquestive Therapeutics, Inc.$981
- plus $7K from 34 others
Across 625 payments — averaging $3910.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1.8M
- Otsuka Pharmaceutical Development & Commercialization, Inc.$268K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$216K
- Biohaven Pharmaceutical Holding Company Ltd.$65K
- Eli Lilly$45K
- Biohaven Pharmaceuticals, Inc.$26K
- plus $21K from 1 others
What the payments were for
- Speaking & faculty fees$50,15063%
- Travel & lodging$10,50513%
- Food & beverage$19,21824%
- Education$250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$46,759
- Jornay PM 20mg capsules (Bottle of 100)$11,798
- INGREZZA$913
- XCOPRI$592
- Epidiolex$522
- Fintepla$358
- VALTOCO$346
- ZTALMY$269
- APTIOM$244
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$134
- Azstarys$128
- SYMPAZAN$120
- ACTHAR$114
- Briviact$114
- Dyanavel XR$107
- Quillichew ER$107
- Quillivant$107
- VIGPODER$104
How this compares
$79,899 in reported general payments places this provider in the 85th percentile of 47 neurology with special qualifications in child neurology providers in Tennessee.
See all neurology with special qualifications in child neurology providers in Tennessee →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SabrilVigabatrin | 23 | $871,383 |
| AfinitorEverolimus | 11 | $216,236 |
| XcopriCenobamate | 41 | $79,466 |
| EpidiolexCannabidiol (Cbd) | 13 | $59,549 |
| TrileptalOxcarbazepine | 36 | $50,758 |
| SympazanClobazam | 11 | $42,019 |
| Oxcarbazepine | 47 | $3,895 |
| Lacosamide | 19 | $1,636 |
| Zonisamide | 35 | $1,613 |
| CarbatrolCarbamazepine | 11 | $1,094 |
| Methylphenidate ErMethylphenidate Hcl | 11 | $1,069 |
| Lamotrigine | 35 | $918 |
| Risperidone | 34 | $638 |
| Levetiracetam | 20 | $557 |
| Topiramate | 18 | $232 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisAfinitor | $15 | $216,23611 claims |
| SK Life Science, Inc.Xcopri | $3,262 | $79,46641 claims |
| Aquestive Therapeutics, Inc.Sympazan | $981 | $42,01911 claims |
| Upsher-smith Laboratories LLCTopiramate | $55 | $23218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 47 neurology with special qualifications in child neurology providers in Tennessee.
Other neurology with special qualifications in child neurology in Nashville
- Jesus Pina GarzaNashville$1.4M
- Jeffrey NeulNashville$127K
- William BurnetteNashville$23K
- Cary FuNashville$19K
- Timothy LivingstonNashville$14K
- Ngochanh VuNashville$4K
- Kaitlin JamesNashville$2K
- Lori JordanNashville$2K
- Michael McCormackNashville$1K
- Robert CarsonNashville$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.